Demystifying Quality and Regulatory Workshop Insights
March 27, 2025

Demystifying Quality and Regulatory Workshop Insights

Regulatory Pathway

Hosted by the HealthTech Activator and Te Tītoki Mataora, this session provided a great opportunity to explore the crucial role that quality systems, risk management, and regulatory strategies play in the success of medical devices and, most importantly, in ensuring patient and user safety.

Key Takeaways:

Why does Q&R matter? The importance of strong regulatory oversight has been demonstrated time and time again by historical events, from thalidomide to the PIP breast implant scandal. These incidents led to tighter regulations, emphasising patient safety, product effectiveness, and compliance. It is crucial to always remember why you're on this journey—ensuring that the right product reaches the right patient, at the right time, and at the right price.

Quality is Everyone’s Responsibility. A robust Quality Management System (QMS) doesn’t just catch mistakes—it helps prevent them. We discussed why ISO 13485 is crucial and how fostering a quality-driven culture enables teams to identify potential issues early on and continuously improve processes. Early in the Product Development Process (PDP), the importance of quality is often underestimated, which can lead to delays later on. It is essential to establish at least the critical quality system elements to support PDP, including document control, change control, design control, and risk management.

Navigating Market Needs & Regulatory Strategy

  • Understanding your users—clinicians, patients, or payers—is essential. Products must align with real-world needs and regulatory requirements, and it’s crucial to consider reimbursement pathways from the start. A strategic approach can often be the most effective route, beginning with a simple indication and expanding as needed.
  • Verification vs Validation – Are We Building the Right Thing? Verification ensures a product meets design specifications, while validation confirms that it works for the intended users. Both are critical to preventing costly failures before launching a product to market.
  • Risk & Compliance – Thinking Beyond Approval. Ensuring clinical effectiveness, patient safety, and regulatory compliance doesn’t stop at product approval. Post-market surveillance is key for refining claims and ensuring continued safety and effectiveness.
  • The Right Regulatory Pathway Matters. Product classification drives regulatory requirements. Whether pursuing a 510(k) in the US, CE marking in the EU, or TGA approval in Australia, having a well-informed regulatory strategy is essential for market success.

Final Thoughts

This workshop reinforced that Q&R strategies aren’t just formalities - they are essential to both patient safety and business success.

By integrating early regulatory planning, proactive risk management, and fostering a culture of quality, we can bring safe, effective, and innovative healthcare solutions to market. Creating a solid foundation early on will help ensure a smoother path to success, avoiding delays and setbacks in the later stages of product development.

It was inspiring to see such great engagement and collaboration throughout the session! We look forward to seeing how attendees apply these insights in their journeys. If you missed this workshop, keep an eye out for future sessions and resources.

What Attendees Had to Say

"Very informative and interactive."
"The workshop was well run with a good structure and plenty of time for questions. Naty and Yaara were generous with their advice and sharing their own experiences."
"I learned a lot of nuanced knowledge that wouldn't be possible to get in a larger lecture-style presentation."

Are you a HealthTech Innovator interested in learning more about regulatory requirements? Keep an eye out for upcoming workshops on the Events page.

Download
Download PDF
Download
Read on External Site